The 7th R&D Sourcing & Procurement in Pharma Summit returns to Boston this May!

It’s an exciting time for modern medicine, with scientific breakthroughs seen in novel targets and cell & gene therapy modalities signifying the race is on for biopharma to accelerate their pipeline products to market.

As investment in promising R&D is at an all time high, procurement and sourcing professionals are faced with increasing responsibility to safeguard pipeline progress and profitability.

In order to stay one-step ahead of fast-moving programs, the 7th R&D Sourcing & Procurement in Pharma Summit is industry’s definitive platform to address both the innovation and obstacles facing preclinical and clinical phase pipelines to give your strategy the edge.

Over 3-Days, gain industry-leading insight and practical takeaways from 35+ Procurement, Sourcing, Category Management & Technology leaders. With Gilead, BMS, Takeda, GSK, I-Mab Biopharma & many more large pharma and biotech contributors, your team won’t want to miss:

  • Which technologies and analytic innovations you can tap into for building efficiencies into both preclinical and clinical R&D, as well as procurement operations?
  • How to combat changing external pricing pressures to safeguard budget predictability, improve operating margins and create assurance in supply
  • Select and nurture relationships with strategic suppliers, tapping into savings, flexibility, capacity and innovation through robust SRM
  • Leverage internal and external expertise for proactively planning R&D and reducing contract cycle timelines
  • Scale up R&D with competitive partnering in cell & gene therapy pipelines, streamlining manufacturing in highly competitive and regulated markets
  • Pursue standardization in procurement, with consistency in external and internal evaluation metrics defining how you’re meeting your business’ goals

Make sure you’re in the room for exclusive intelligence and 8+ hours of networking with 120+ industry trailblazers this May!